New Product Launch

Juno Pharmaceuticals is proud to announce the launch of Bortezomib. We are committed to providing innovative solutions to address patient needs and ensuring availability to those who require it. Our goal is to advance patient care through research, development, and innovative treatment options.



Bortezomib for Injection treats multiple myeloma and mantle cell lymphoma, used for previously untreated and relapsed patients. It's used as part of combination therapy and for those unsuitable for stem cell transplantation. The medication is also used for patients with mantle cell lymphoma who have undergone one prior therapy.

 

.